Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Heidelberg
NRG Oncology
EBG MedAustron GmbH
Mayo Clinic
M.D. Anderson Cancer Center
University Hospital Heidelberg
M.D. Anderson Cancer Center
Emory University
Emory University
Mayo Clinic
NRG Oncology
NRG Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Mayo Clinic
Massachusetts General Hospital
Emory University
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Proton Collaborative Group
Emory University
NRG Oncology
Mayo Clinic